In 2007, the Sixth European Congress of Gerontology was held in St. Petersburg. It was a great honor for the team of founders and developers of NPCRIZ to become a participant of this landmark event. Today, the team `NPCRIZ`, as strategic partner of the St.-Petersburg Institute of Bioregulation and Gerontology, participates in large-scale study of the efficiency of peptide bioregulators. The results of this study were reported in April 2011 in Bologna at the Seventh European Congress of Gerontology, in June 2013 at the XX World Congress of Gerontology and Geriatrics in Seoul, and in April 2015 in Dublin at the VIII European Congress of Gerontology and Geriatrics.

Having accumulated a huge store of knowledge and experience with peptides and other classes of geroprotectors, NPCRIZ company has developed step by step schemes recommended by us in various pathologies. It is an active anti-ageing and preventive program.


Most of the medicines, which are recommended in the submitted schemes, relate to the class of parapharmaceuticals. Features of their specification and implementation involve in the “instructions for use” to write “with a meal” as parapharmaceuticals formally belong to the class of supplements. Therefore, on the packaging, the instructions for use and catalogs we refer to take medicines before a meal. However, in the brochures of the complex application, in most cases we specify on taking medicines before a meal, as we believe this is the most correct. It is in this case provides maximum bioavailability and thus medicine’s efficacy.

Vice President NPCRIZ for Science,

Ph.D., MD, Gorgiladze D.A.